The pharmaceutical and life sciences industry is undergoing a major CRM transformation. Veeva Systems is officially ending its reliance on Salesforce's platform to transition to its proprietary Vault ecosystem. With the formal separation set to begin in September 2025, companies must now make strategic decisions about their CRM infrastructure. While the original wind-down period was slated for 2030, Veeva recently accelerated the end-of-support deadline for the legacy Salesforce-based CRM to December 31, 2029
Transitioning to the Salesforce Life Sciences Cloud isn't just a technical necessity; it’s an opportunity to reclaim your team’s capacity to innovate. At Minuscule Technologies, we shift the focus from reactive data porting to strategic platform evolution. We help you navigate the complexity of clinical trial automation and AI-driven engagement, transforming your CRM into an agile, patient-centric ecosystem.
Is your organization ready for the post-Veeva era? Explore the full guide below or collaborate with us to build a migration roadmap tailored to your clinical and commercial goals.
Introduced in June 2024, Salesforce Life Sciences Cloud leverages the capabilities of Health Cloud, Marketing Cloud, Service Cloud, and Data Cloud to provide an end-to-end ecosystem. Organizations choose this route for several strategic advantages:
Migrating your CRM requires careful planning to prevent data loss, compliance gaps, and operational downtime. Follow these best practices for a successful transition:
Begin by mapping your current CRM architecture, including all systems, data flows, and integrations. Evaluate your organization's readiness to adopt advanced capabilities like AI and intelligent automation. It is critical to identify sensitive, regulated data that will require special handling to mitigate FDA, EMA, or HIPAA compliance risks during the transfer.
Industry research indicates that between 30% and 70% of CRM data can be inaccurate or outdated. Migrating disorganized data will only replicate problems in your new system. Profile and deduplicate your records, aiming for at least 95% data accuracy before you initiate the switch-over.
Veeva CRM users often rely on custom third-party integrations like ERPs or clinical databases. Customer-developed custom objects and Apex code will not automatically migrate. IT teams must prepare to rebuild custom logic using integration platforms like MuleSoft, Informatica, Dell Boomi, or Jitterbit, which offer pre-built connectors to automate complex data pipelines.
Set up a dedicated sandbox in Salesforce or a test environment to run trial operations. Perform test migrations with a subset of data and workflows to validate accuracy, system performance, and compliance. Use this test environment to identify any unmapped fields or integration breakages before going live.
Avoid a "big bang" approach by using agile methodologies to break the migration into manageable sprints or phased regional rollouts. Utilize robust ETL (Extract, Transform, Load) platforms to extract data, transform it into compatible formats like SQL or CSV, and load it securely into Salesforce. Ensure that unique external IDs are mapped diligently, as using external identifiers is a best practice for linking records accurately and preventing duplicates.
User resistance and a lack of training can derail even the most technically sound projects, with up to 70% of CRM migrations failing due to poor planning and training. Communicate with the
transition plan clearly, identify field ambassadors to advocate for the system, and develop role-based training programs to ensure smooth adoption.
Launch the system in phases to minimize business disruption. Establish a "hypercare" period with a dedicated support team and ticketing system to monitor and resolve issues immediately under agreed SLAs. Run a comprehensive post-migration audit to verify that all record counts match the source, validate critical workflows, and ensure all audit logs are preserved for regulatory compliance
The Veeva-Salesforce split refers to Veeva Systems ending its long-standing partnership with Salesforce to move its CRM off the Salesforce platform and onto its own proprietary Vault platform. The formal separation begins in September 2025. Veeva has accelerated the end-of-support timeline for the legacy Salesforce-based CRM to December 31, 2029.
Introduced in June 2024, Salesforce Life Sciences Cloud is a CRM solution tailored specifically for pharmaceutical and medtech companies. It combines the capabilities of Health Cloud, Marketing Cloud, Service Cloud, and Data Cloud, leveraging AI to streamline clinical trials, drug deployment, and personalized patient experiences.
Organizations operating beyond strictly life-sciences workflows often prefer Salesforce Life Sciences Cloud for its cross-industry adaptability. Salesforce offers highly flexible customization, native Einstein AI and autonomous Agentforce agents, and the ability to maintain a single ecosystem across marketing, finance, and field teams.
The primary challenges include migrating complex custom objects and custom Apex code that will not automatically transfer. Businesses must also manage potential data loss, handle the complexity of rebuilding custom integrations with ERPs or clinical databases, and properly train their sales teams to prevent productivity loss.
A successful migration requires conducting a thorough data audit and aiming for at least 95% record accuracy before switching over. Companies should utilize robust ETL middleware tools - such as MuleSoft or Informatica - and ensure unique external IDs are leveraged to accurately link records and prevent duplicates during the transition.
The Salesforce-Veeva split is more than an IT migration; it is an opportunity to rethink your engagement strategy. With the window to act closing as we approach 2029, proactive planning is the only way to avoid compliance gaps and operational downtime.
By transitioning to Salesforce Life Sciences Cloud, your organization breaks free from legacy limitations. You gain the power of advanced AI and the agility of an omnichannel platform. When you treat this migration as a strategic launchpad rather than a routine update, you safeguard your data and ensure your system scales alongside the next generation of medical breakthroughs.
Are you concerned about data loss or productivity gaps during the Veeva transition? Don't let the accelerated deadline catch you off guard. At Minuscule Technologies, Trusted Salesforce Engineering Partner, we specialize in architecting seamless Salesforce migrations that protect your regulatory standing and empower your field teams.
Collaborate with Minuscule Technologies Today. Let’s build a secure, AI-powered Life Sciences ecosystem that thinks, acts, and scales as fast as your ambition.
You've seen what's possible. Now, let's make it happen for your business. Whether you need an end-to-end Salesforce solution, a complex integration, or ongoing managed services, our team is ready to deliver.
Schedule a Free Strategic Call
